Thermo Fisher Scientific Inc.

TMO · NYSE · USD

Historical Earnings

QuarterReportedEPS estEPS actSurpriseRev estRev actSurpriseReaction
Q3 2026Oct 21, 20266.406.68+4.4%$12.0B$12.1B+1.5%−2.52%
Q2 2026Jul 23, 20265.726.03+5.4%$11.7B$12.0B+2.5%−0.71%
Q1 2026Apr 23, 20265.255.44+3.6%$10.9B$11.0B+1.3%+0.64%
Q4 2025Jan 29, 20266.456.57+1.9%$11.9B$12.2B+2.2%−2.29%
Q3 2025Oct 22, 20255.505.79+5.3%$10.9B$11.1B+1.9%+0.83%
Q2 2025Jul 23, 20255.235.36+2.5%$10.7B$10.9B+1.6%+1.78%
Q1 2025Apr 23, 20255.105.15+1.0%$10.2B$10.4B+1.3%−1.15%
Q4 2024Jan 30, 20255.946.10+2.7%$11.3B$11.4B+1.0%−1.48%

Detailed View

Q4 2026Feb 4, 2027Q3 2026Oct 21, 2026−2.52%Q2 2026Jul 23, 2026−0.71%Q1 2026Apr 23, 2026+0.64%Q4 2025Jan 29, 2026−2.29%Q3 2025Oct 22, 2025+0.83%Q2 2025Jul 23, 2025+1.78%Q1 2025Apr 23, 2025−1.15%Q4 2024Jan 30, 2025−1.48%Q3 2024Oct 23, 2024−3.31%Q2 2024Jul 24, 2024Q1 2024Apr 24, 2024
2026 Q3 Metrics
MetricEstimateActualSurpriseY/Y
Revenue$12.0B$12.1BBeat +1.54%+9.1%
EPS6.406.68Beat +4.37%+15.4%
Diluted EPS (GAAP)—4.64—+8.7%
Documents

No filings for this quarter yet.

Filings appear here once the print is on file with the SEC.